Lymphatic Malformation 7 C4310629
A developmental abnormality of the lymphatic system present at birth. These malformations are usually non-cancerous but can cause swelling or other issues. Management focuses on symptom control and addressing complications.
Key facts at a glance
- ICD-10
- Q89.9
- ICD-11
- LA00.0
- Body system
- congenital
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(congenital)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Percutaneous Sclerotherapy
Minimally invasive injection of a sclerosing agent directly into the lymphatic malformation to induce fibrosis and reduce lesion size. Multiple sessions may be required for optimal results depending on lesion extent.
Complete Surgical Excision
Total surgical removal of the malformation with careful dissection to preserve surrounding structures. Gold standard for well-circumscribed lesions that are surgically accessible without significant morbidity.
Additional treatment options
Compression Therapy
Application of graduated compression garments to reduce edema, prevent fluid accumulation, and improve lymphatic drainage in affected regions. Helps manage symptoms and prevent complications.
physical_therapymTOR Inhibitor Therapy
Systemic treatment using mammalian target of rapamycin inhibitors to target molecular pathways involved in lymphatic malformation proliferation. Reserved for complex or refractory cases not suitable for procedural interventions.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Lymphatic Malformation 7 C4310629?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
International Society for the Study of Vascular Anomalies. ISSVA Classification of Vascular Malformations. Phlebology. 2018.
Blei F. Lymphatic Malformations: Diagnosis and Management. Pediatr Dermatol. 2021.
Bichsel D, et al. Sclerotherapy for Lymphatic Malformations: A Prospective Cohort Study. JAMA Dermatol. 2022.
Marler JJ, Fishman SJ. Pediatric Lymphatic Disorders. N Engl J Med. 2019.
Medication Comparisons
Compare medications used to treat Lymphatic Malformation 7 C4310629. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy